Prospect News: News for ConMed Corp.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with C > Issuers starting with C, CV only > All stories on ConMed Corp. > Stories on ConMed Corp., CV only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

ConMed Corp.

6/10/2022	CV	Market Commentary: Altair convertibles down outright, flat on swap; ConMed contracts; travel names eyed
6/8/2022	CV	Market Commentary: ConMed convertible notes come in; Asian names ‘hot’ in secondary market; Zendesk active
6/8/2022	CV	Market Commentary: Morning Commentary: ConMed convertible notes in focus early, trade down outright
6/7/2022	CV	ConMed greenshoe exercised, lifts 2.25% convertibles to $800 million
6/7/2022	CV	Market Commentary: Morning Commentary: Redwood Trust’s new convertible notes due 2027 trade at 100-100.5
6/6/2022	CV	Market Commentary: Redwood Trust convertible notes eyed; Snap lifted; ConMed slows; Okta trades lower
6/3/2022	CV	Market Commentary: ConMed convertibles give back outright gains; Okta up post-earnings; Novavax below par
6/2/2022	CV	Market Commentary: ConMed convertible notes jump on debut; NextEra active; Public Storage gains outright
6/2/2022	CV	Market Commentary: Morning Commentary: ConMed convertible notes dominate early trading, jump on debut
6/2/2022	CV	New Issue: ConMed prices upsized $700 million five-year convertibles to yield 2.25%, up 30%
6/1/2022	CV	Market Commentary: ConMed convertible notes offering eyed; Integra LifeSciences active; Beyond Meat higher
6/1/2022	CV	Market Commentary: Morning Commentary: ConMed convertible notes offering eyed; Tellurian prices overnight
5/31/2022	CV	Market Commentary: ConMed convertibles on tap; Asian names rally; Pinduoduo jumps; Insulet up on swap
5/31/2022	CV	ConMed talks $600 million five-year convertible notes at 2.25%-2.75%, up 27.5%-32.5%
1/29/2019	CV	Market Commentary: NIO on tap; Square convertibles expand; Illumina active pre-earnings; Tesla in focus
1/28/2019	CV	Market Commentary: Western Digital convertible notes in focus; Illumina, Tesla active; ConMed comes in
1/25/2019	CV	Market Commentary: ConMed convertibles expand on debut; Western Digital rallies; Illumina notes contract
1/25/2019	CV	Market Commentary: Morning Commentary: ConMed convertibles hit the market, expand; Western Digital active
1/24/2019	CV	New Issue: ConMed prices upsized $300 million five-year convertibles to yield 2.625%, up 27.5%
1/24/2019	CV	Market Commentary: ConMed convertible notes come upsized after price talk tightened; semiconductors active
1/24/2019	CV	ConMed tightens talk on $275 million five-year convertible notes to yield 2.625%-2.875%, up 27.5%
1/24/2019	CV	Market Commentary: Morning Commentary: ConMed convertible notes offering eyed; Microchip Technology active
1/23/2019	CV	Market Commentary: ConMed convertibles on tap; Tilray up; Exact Sciences expands; Citrix, Illumina active
1/23/2019	CV	ConMed talks $275 million five-year convertibles at 2.875%-3.375%, up 22.5%-27.5%
12/13/2018	BKCV	ConMed to use expanded credit facility, convertibles for acquisition
4/3/2012	BKCV	ConMed continues debt reduction, eyes operating margin goal of 14%
2/15/2012	CVLM	ConMed holders exercise put for all 2.5% convertible notes
2/28/2011	BKCVHY	S&P cuts ConMed loans
10/29/2009	BKCVHY	Moody's affirms ConMed
4/24/2009	CV	ConMed buys back $9.9 million more 2.5% convertibles at 21% discount in first quarter
2/23/2009	BKCVHY	S&P cuts ConMed outlook to stable
1/6/2009	CV	Conmed to 'keep an eye on' 2.5% convertibles in 2009
1/5/2009	CV	Conmed buys back $25 million 2.5% convertibles at 20% discount
2/22/2008	BKCVHY	S&P lifts ConMed
1/9/2008	BKCVHY	S&P: ConMed view positive
11/28/2007	BKCV	Moody's ups ConMed loans to Ba1, notes to B1
3/24/2006	BKCV	S&P gives ConMed loan BB-
3/24/2006	BKCV	Moody's assigns ConMed loan Ba2
11/17/2004	BKCV	Moody's rates ConMed converts B2
11/11/2004	CV	Conmed greenshoe exercised, raising convertibles to $150 million
11/5/2004	CV	New Issue: Conmed $125 million convertibles yield 2.5%, up 42.5%
11/5/2004	CV	Market Commentary: Conmed new issue trades stronger; Ryerson Tull, Powerwave head lower
11/4/2004	BKCVHY	S&P rates ConMed convertibles B
11/4/2004	CV	Conmed $125 million convertibles yield 2.5%
11/4/2004	CV	Market Commentary: Calendar additions appreciated but some long for days of larger convertible offerings
11/3/2004	CV	Conmed to sell $125 million convertible notes
11/3/2004	CV	Market Commentary: Oil companies' convertibles spike higher in celebration of Bush re-election

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.